Mr James Carlisle Foster Iv, APRN | |
322 Watson Rd, Travelers Rest, SC 29690-2221 | |
(864) 430-6725 | |
Not Available |
Full Name | Mr James Carlisle Foster Iv |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 322 Watson Rd, Travelers Rest, South Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063017820 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | 24195 (South Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr James Carlisle Foster Iv, APRN 322 Watson Rd, Travelers Rest, SC 29690-2221 Ph: (864) 430-6725 | Mr James Carlisle Foster Iv, APRN 322 Watson Rd, Travelers Rest, SC 29690-2221 Ph: (864) 430-6725 |
News Archive
In innumerable spy movies, the hero or a villain imprints a key in clay in order to later make an exact copy. In the body, the clay is messenger RNA, or mRNA, which imprints a gene and transfers the plans to a ribosome, where the mRNA's code is manufactured into a protein - the shady shop where the clay imprint becomes a key.
Eisai Inc., the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., and FORMA Therapeutics announced today that the two companies have signed a strategic drug discovery collaboration.
Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated enrollment in its confirmatory Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating orBec(®) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD).
ToolGen, Inc., a biotechnology company specializing in genome editing, today announced data demonstrating that blocking a molecular pathway that down-regulates T-cell activity with the Company's CRISPR/Cas9 gene editing platform results in increased T-cell receptor signaling, in vitro, and in improved anti-tumor activity when tested against in a mouse glioblastoma tumor model.
› Verified 9 days ago
Sherry Josette Lindsay, N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1 Havenwood Ln, Travelers Rest, SC 29690 Phone: 864-834-8013 Fax: 864-834-6977 | |
Michaela Oldham, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 228 S Main St, Travelers Rest, SC 29690 Phone: 864-610-0838 | |
Kara Price, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 135 Botanical Circle, Travelers Rest, SC 29690 Phone: 864-836-5322 Fax: 864-371-1812 | |
Mrs. Stacey Dilworth, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 200 N Highway 25, Travelers Rest, SC 29690 Phone: 866-389-2727 | |
Sarah Nunn Hall, CPNP-PC APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1 Havenwood Ln, Travelers Rest, SC 29690 Phone: 864-834-8013 Fax: 864-834-6977 | |
Audrey Goodjoin, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 807 N Main St, Travelers Rest, SC 29690 Phone: 864-834-5132 |